A detailed history of Capital Fund Management S.A. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Capital Fund Management S.A. holds 581,359 shares of IRWD stock, worth $2.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
581,359
Previous 305,621 90.22%
Holding current value
$2.58 Million
Previous $1.99 Million 19.93%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.93 - $7.04 $1.08 Million - $1.94 Million
275,738 Added 90.22%
581,359 $2.39 Million
Q2 2024

Aug 13, 2024

BUY
$5.58 - $8.61 $1.71 Million - $2.63 Million
305,621 New
305,621 $1.99 Million
Q1 2023

May 15, 2023

SELL
$10.37 - $12.56 $2.86 Million - $3.47 Million
-275,902 Reduced 87.71%
38,646 $406,000
Q4 2022

Feb 13, 2023

BUY
$9.9 - $12.43 $668,873 - $839,808
67,563 Added 27.36%
314,548 $3.9 Million
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $1.29 Million - $1.58 Million
127,532 Added 106.76%
246,985 $2.56 Billion
Q2 2022

Aug 12, 2022

BUY
$11.05 - $12.72 $479,558 - $552,035
43,399 Added 57.06%
119,453 $1.38 Million
Q1 2022

May 12, 2022

BUY
$10.61 - $12.88 $378,034 - $458,914
35,630 Added 88.14%
76,054 $956,000
Q4 2021

Feb 10, 2022

SELL
$10.86 - $13.95 $20,775 - $26,686
-1,913 Reduced 4.52%
40,424 $471,000
Q3 2021

Nov 12, 2021

BUY
$11.92 - $13.92 $62,150 - $72,578
5,214 Added 14.05%
42,337 $552,000
Q2 2021

Aug 12, 2021

BUY
$10.16 - $13.11 $160,842 - $207,544
15,831 Added 74.35%
37,123 $477,000
Q1 2021

May 14, 2021

SELL
$9.04 - $11.86 $67,302 - $88,297
-7,445 Reduced 25.91%
21,292 $238,000
Q4 2020

Feb 12, 2021

BUY
$9.05 - $12.2 $260,069 - $350,591
28,737 New
28,737 $327,000
Q4 2019

Feb 13, 2020

SELL
$8.22 - $14.0 $91,242 - $155,400
-11,100 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$8.59 - $10.96 $95,349 - $121,656
11,100 New
11,100 $95,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $679M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.